Global Gammaretroviral Vector Market – Industry Trends and Forecast to 2030

Análisis y tamaño del mercado de vectores gammaretrovirales

Los retrovirus son portadores de genes adaptados de forma natural que han evolucionado para transportar eficazmente sus ácidos nucleicos a la cromatina de la célula diana, superando así las barreras celulares naturales. El virus de la leucemia murina (MLV), un gammaretrovirus simple, puede convertirse en un vehículo eficaz de terapias genéticas, comenzando con un estudio más profundo de la biología retroviral. Los vectores retrovirales son vehículos de transporte de ácidos nucleicos fascinantes y eficaces. Todos los retrovirus pueden transcribir de forma inversa su genoma de ARN monocatenario en ADN bicatenario, que luego se integra de forma estable en el genoma de la célula huésped. Como parásitos altamente evolucionados, trabajan con factores celulares del huésped para transportar su ácido nucleico al núcleo, donde utilizan la maquinaria de la célula huésped para la replicación y la expresión a largo plazo.

Data Bridge Market Research analiza el mercado de vectores gammaretrovirales, que se espera que alcance una CAGR del 17,7 % durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de la cartera de proyectos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de vectores gammarretrovirales      

Definición de mercado

Los gammaretrovirus son vectores retrovirales en estudios de laboratorio. Estos vectores son fundamentales para la terapia génica y la transferencia de genes. Son muy útiles porque sus genomas son simples y fáciles de usar. Los gammaretrovirus tienen una amplia gama de implicaciones para los animales. Se han relacionado con varias enfermedades, incluido el cáncer, específicamente leucemias y linfomas, enfermedades neurológicas e inmunodeficiencias en múltiples especies. Los gammaretrovirus, al igual que otros retrovirus, transcriben de forma inversa un ARN monocatenario positivo en ADN bicatenario. El ADN bicatenario es muy estable y se integra fácilmente en el genoma del huésped. El virus de la leucemia murina de Moloney, el virus xenotrópico relacionado con MuLB, el virus de la leucemia felina y el virus del sarcoma felino son algunos ejemplos de este virus.

Dinámica del mercado mundial de vectores gammarretrovirales

Conductores

• Aumento de la prevalencia del cáncer y de los trastornos genéticos

Según la Organización Mundial de la Salud, el cáncer de pulmón es la principal causa de muerte por cáncer, seguido del cáncer de mama y el cáncer colorrectal. El cáncer de mama, el cáncer de pulmón, el cáncer de próstata, el cáncer de colon y el cáncer de recto son los cánceres más frecuentes. La creciente frecuencia del cáncer, las enfermedades genéticas y las enfermedades infecciosas está impulsando la demanda de tratamientos genéticos basados ​​en vectores, terapias celulares y vacunas, que es uno de los principales impulsores del mercado mundial de vectores gammaretrovirales.

• Rápida adopción de vectores virales y plasmídicos para el desarrollo de terapias innovadoras

Se están desarrollando rápidamente nuevos medicamentos utilizando vectores virales y no virales. Estos vectores son útiles para administrar un gen a una célula o tejido específico in vivo. Los virus adenoasociados, los lentivirus y los retrovirus son ejemplos de vectores virales que se han empleado en varios ensayos clínicos y preclínicos para evaluar productos de terapia génica y celular y vacunas.

Además, el desarrollo de líneas celulares productoras estables durante el procesamiento previo puede ofrecer numerosas ventajas en comparación con los métodos de transfección transitoria. Además de ahorrar dinero en plásmidos y agentes de transfección de calidad clínica, las partículas virales producidas por líneas celulares estables suelen ser de mayor calidad. Como serán casi homólogas, reducirán la posible variabilidad entre lotes y proporcionarán cosechas más limpias. Las líneas celulares productoras estables también son más escalables que los métodos de transfección transitoria y se pueden utilizar para la producción a pequeña o gran escala según las cantidades requeridas.

• Favourable funding scenario for vector-based therapies

High expense of producing and developing a new medicine, preclinical and clinical trials to determine its effectiveness require enough funding. The abundant grants and finances available for undertaking research and development activities connected to vector-based cell and gene therapies propelling the gammaretroviral vector market.

Opportunities

• Rising prevalence of diseases

The rising prevalence of diseases such as heart disease, cancer, HIV, and haemophilia has necessitated the development of viral vector-based therapeutics, with technological advancements in viral vector manufacturing driving market expansion. Furthermore, expanding biopharmaceutical industry usage of viral vectors and increasing cost-effective treatments are driving market demand.

Restraints/Challenges

• High cost

High cost of production and gene therapies will limit the growth of gammaretroviral vector market in the forecast period of 2023 to 2030.

This gammaretroviral vector market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gammaretroviral vector market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Gammaretroviral Vector Market Scope

The gammaretroviral vector market is segmented on the basis of type, disease type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Lentiviral Vectors
• Adenoviral Vectors
• Adeno-Associated Viral Vectors
• Other

Disease Type

• Cancer
• Genetic Disorders
• Infectious Diseases
• Other

 Application

• Gene Therapy
• Vaccinology

End-User

• Pharmaceutical and Biopharmaceutical
• Research Institutes

Gammaretroviral Vector Market Regional Analysis/Insights

The gammaretroviral vector market is analyzed and market size insights and trends are provided by country, type, disease type, application and end-user as referenced above.

The countries covered in the gammaretroviral vector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gammaretroviral vector market due to the rising advancement in medical treatment procedures and growing healthcare expenditure.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the rising demand for efficient treatment procedure, increasing funding for gene therapies, and government initiatives for R&D activities in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The gammaretroviral vector market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gammaretroviral vector market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gammaretroviral vector market. The data is available for historic period 2011-2021.

Competitive Landscape and Gammaretroviral Vector Market Share Analysis

The gammaretroviral vector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gammaretroviral vector market.

Some of the major players operating in the gammaretroviral vector market are:

• Novasep (France)
• MerckKGaA (Germany)
• Charles River Laboratories (U.K.)
• uniQure N.V. (Netherlands)
• Waisman Biomanufacturing (U.S.)
• Creative-Biogene (U.S.)
• Aldevron (U.S)
• Addgene (U.S.)
• Oxford Biomedica (U.K.)
• Thermo Fisher Scientific Inc (U.S.)
• Fujifilm Corporation (Japan)
• Spark Therapeutics Inc. (U.S.)
• ABL Inc. (U.S.)
• Boehringer Ingelheim International GmbH. (Germany)
• Brammer Bio (U.S.)
• Creative Biogene (U.S.)
• General Electric (U.S.)
• Pfizer Inc. (U.S.)

Research Methodology: Global Gammaretroviral Vector Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

SKU-56408